Cargando...
P14.23 Risk of venous thromboembolism (VTE) in grade II-IV gliomas as a function of molecular subtype
BACKGROUND: VTE affects up to 30% of patients with glioblastoma (GBM, WHO grade IV), but little is known about its incidence in lower-grade gliomas (LGG, WHO grade II-III). It has been suggested that isocitrate dehydrogenase (IDH) mutation status dramatically decreases the incidence of VTE in glioma...
Guardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6795921/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.258 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|